MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Myoclonus-Dystonia Syndrome Due to a Novel Mutation in the Epsilon-Sarcoglycan (SGCE) Gene

C. Gonzalez Robles, A. Rojo Sebastian, J. Garcia Diaz (Alcala de Henares, Spain)

Meeting: 2019 International Congress

Abstract Number: 1279

Keywords: Dystonia: Genetics, Myoclonus: Genetics

Session Information

Date: Tuesday, September 24, 2019

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To present a case report of a patient with myoclonus-dystonia in whom a mutation in the epsilon-sarcoglycan gene which has not been previously described, was detected.

Background: Myoclonus-dystonia is a clinical syndrome characterized by childhood-onset alcohol-responsive myoclonus (usually the initial symptom), predominantly in the upper body, dystonia and psychiatric disorders, especially obsessive-compulsive disorder and anxiety. The main responsible gene is epsilon-sarcoglycan gene (SGCE), with an autosomal dominant inheritance pattern and maternal imprinting. Several pathogenic variations of the SGCE gene related to myoclonus-dystonia have already been described.

Method: A 41-year-old woman presented with brief muscle jerks since age 12, which improved with alcohol. Furthermore, she suffered from anxiety and had occasionally complained of neck and back stiffness. Her paternal grandmother and two paternal great aunts presented early-onset myoclonus which stabilized with age, tremor and parkinsonism, and her sister complained of mild tremor. Her father and brother were asymptomatic.

Results: At examination, the patient presented trunk, cervical and upper-limb myoclonus, as well as cervical dystonia. Brain magnetic resonance imaging, electroencephalogram, blood tests for secondary dystonia (including copper and ceruloplasmin) and cerebrospinal fluid analysis were all normal. A molecular study of the SGCE gene showed a previously undescribed heterozygous mutation (c.694_825+148delinsCAGTGCA o p.Asp229Glufs*14), which produces a premature stop codon (truncated protein) or an alternative splicing, both of them very probably pathogenic. After several pharmacological measures, she is currently in treatment with piracetam.

Conclusion: Myoclonus-dystonia is a well-described entity but its genetic substrate is complex and expanding. The SGCE gene mutation here communicated has a high probability of pathogenicity and should be taken into consideration when future patients are genetically tested and counselled.

To cite this abstract in AMA style:

C. Gonzalez Robles, A. Rojo Sebastian, J. Garcia Diaz. Myoclonus-Dystonia Syndrome Due to a Novel Mutation in the Epsilon-Sarcoglycan (SGCE) Gene [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/myoclonus-dystonia-syndrome-due-to-a-novel-mutation-in-the-epsilon-sarcoglycan-sgce-gene/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/myoclonus-dystonia-syndrome-due-to-a-novel-mutation-in-the-epsilon-sarcoglycan-sgce-gene/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley